Strategic Outlook 2026: Navigating the Global Nortriptyline Hydrochloride Market
As of early 2026, the global nortriptyline hydrochloride market has solidified its position as a resilient pillar within the broader antidepressant drugs market. While newer-generation SSRIs and SNRIs dominate first-line therapy, nortriptyline—a second-generation tricyclic antidepressant (TCA)—continues to capture significant value in specialized therapeutic segments. The market, valued at approximately $950.75 million in 2025, is projected … Read more